Compensatory adaptation to the loss of biological fitness associated with acquisition of fusidic acid resistance in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 4, 2005, Pages 1426-1431

  Besier, Silke ^a   Ludwig, Albrecht ^a   Brade, Volker ^a   Wichelhaus, Thomas A ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; BACTERIAL RNA; CHLORAMPHENICOL; COAGULASE; DNA; ERYTHROMYCIN; FUSIDIC ACID;

ADAPTATION; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; ENZYME ACTIVITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; COAGULASE; DRUG RESISTANCE, BACTERIAL; FUSIDIC ACID; HUMANS; PEPTIDE ELONGATION FACTOR G; STAPHYLOCOCCUS AUREUS;

EID: 16244419018     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.4.1426-1431.2005     Document Type: Article

References (29)

1. Andersson, D. I., and B. R. Levin. 1999. The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2:489-493.
2. Andersson, D. I. 2003. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6:452-456.
3. Besier, S., A. Ludwig, V. Brade, and T. A. Wichelhaus. 2003. Molecular analysis of fusidic acid resistance in Staphylococcus aureus. Mol. Microbiol. 47:463-469.
4. Billington, O., T. D. McHugh, and S. H. Gillespie. 1999. Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 43:1866-1869.
5. Björkman, J., I. Nagaev, O. G. Berg, D. Hughes, and D. I. Andersson. 2000. Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287:1479-1482.
6. Bodley, J. W., F. J. Zieve, L. Lin, and S. T. Zieve. 1969. Formation of the ribosome-G factor-GDP complex in the presence of fusidic acid. Biochem. Biophys. Res. Commun. 37:437-443.
7. Brown, E. M., and P. Thomas. 2002. Fusidic acid resistance in Staphylococcus aureus isolates. Lancet 359:803.
8. Chopra, I. 1976. Mechanisms of resistance to fusidic acid in Staphylococcus aureus. J. Gen. Microbiol. 96:229-238.
9. Dufour, P., Y. Gillet, M. Bes, G. Lina, F. Vandenesch, D. Floret, J. Etienne, and H. Richet. 2002. Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin. Infect. Dis. 35:819-824.
10. Godtfredsen, W., K. Roholt, and L. Tybring. 1962. Fusidin. A new orally active antibiotic. Lancet i:928-931.
11. Haima, P., D. van Sinderen, H. Schotting, S. Bran, and G. Venema. 1990. Development of a beta-galactosidase alpha-complementation system for molecular cloning in Bacillus subtilis. Gene 86:63-69.
12. Johanson, U., and D. Hughes. 1994. Fusidic acid-resistant mutants define three regions in elongation factor G in Salmonella typhimurium. Gene 143:55-59.
13. Johanson, U., A. Ævarson, A. Liljas, and D. Hughes. 1996. The dynamic structure of EF-G studied by fusidic acid resistance and internal revertants. J. Mol. Biol. 258:420-432.
14. Kreiswirth, B. N., S. Lofdahl, M. J. Betley, M. O'Reilly, P. M. Schlievert, M. S. Bergdoll, and R. P. Novick. 1983. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature 305:709-712.
15. Kristinsson, K. G. 1997. Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microb. Drug Resist. 3:117-123.
16. Laurberg, M., O. Kristensen, K. Martemyanov, A. T. Gudkov, I. Nagaev, D. Hughes, and A. Liljas. 2000. Structure of a mutant EF-G reveals domain III and possibly the fusidic acid binding site. J. Mol. Biol. 303:593-603.
17. Levin, B. R., V. Perrot, and N. Walker. 2000. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 154:985-997.
18. Macvanin, M., U. Johanson, M. Ehrenberg, and D. Hughes. 2000. Fusidic acid-resistant EF-G perturbs the accumulation of ppGpp, Mol. Microbiol. 37:98-107.
19. Macvanin, M., J. Bjorkman, S. Eriksson, M. Rhen, D. I. Andersson, and D. Hughes. 2003. Fusidic acid-resistant mutants of Salmonella enterica serovar Typhimurium with low fitness in vivo are defective in RpoS induction. Antimicrob. Agents Chemother. 47:3743-3749.
20. Maisnier-Patin, S., O. G. Berg, L. Liljas, and D. I. Andersson. 2002. Compensatory adaptation to the deleterious effect of antibiotic resistance in Salmonella typhimunum. Mol. Microbiol. 2:355-366.
21. Nagaev, I., J. Björkman, D. I. Andersson, and D. Hughes. 2001. Biological cost and compensatory evolution in fusidic acid-resistant Staphylococcus aureus. Mol. Microbiol. 40:433-439.
22. O'Brien, F. G., C. Price, W. B. Grubb, and J. E. Gustafson. 2002. Genetic characterization of the fusidic acid and cadmium resistance determinants of Staphylococcus aureus plasmid pUB101. J. Antimicrob. Chemother. 50:313-321.
23. Philips, I., A. King, W. R. Gransden, and S. J. Eykyn. 1990. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988. J. Antimicrob. Chemother. 25:59-80.
24. Price, C. T., and J. E. Gustafson. 2001. Increase in the mutation frequency at which fusidic acid-resistant Staphylococcus aureus arise with salicylate. J. Med. Microbiol. 50:104-106.
25. Sambrook, J., and D. W. Russell. 2001. Molecular cloning: a laboratory manual, 3rd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. N.Y.
26. Sander, P., B. Springer, T. Prammananan, A. Sturmfels, M. Kappler, M. Pletschette, and E. C. Böttger. 2002. Fitness cost of chromosomal drug resistance-conferring mutations. Antimicrob. Agents Chemother. 46:1204-1211.
27. Turnidge, J., and P. Collignon. 1999. Resistance to fusidic acid. Int. J. Antmicrob. Agents 12:35-44.
28. Wichelhaus, T. A., B. Böddinghaus, S. Besier, V. Schäfer, V. Brade, and A. Ludwig. 2002. Biological cost of rifampicin resistance from the perspective of Staphylococcus aureus. Antimicrob. Agents Chemother. 46:3381-3385.
29. Witte, W., C. Cuny, B. Strommenger, C. Braulke, and D. Heuck. 2004. Emergence of a new community acquired MRSA strain in Germany. Euro. Surveill. 9:1-2.